Award
Delivery Order #SPE2DR26F9UV2
Delivery Order for Daunorubicin Vials to Support Healthcare Needs
Buyer
Defense Logistics Agency
Award Amount
$583.25
Ceiling
$583.25
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26F9UV2
NAICS
424210
This award represents a delivery order contract under the indefinite delivery vehicle previously established with AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The contract involves the procurement of Daunorubicin 20 mg/4 ml vials, a critical chemotherapy medication used in healthcare treatments. This delivery order is part of a broader, long-term pharmaceutical supply agreement designed to ensure timely access to essential medications for healthcare institutions. The scope includes providing specific doses of Daunorubicin to meet imminent medical demand, supporting continuous patient care. Awarded on a competitive basis within the existing contract framework, this short-term delivery is executed promptly to maintain medication availability. The contract was awarded for a brief performance period, emphasizing swift fulfillment aligned with healthcare scheduling needs.
Description
4571085706!DAUNORUBICIN 20 MG/4 ML VIAL 4ML